期刊文献+

柔嫩艾美耳球虫二氢乳清酸脱氢酶基因注释、克隆与原核表达 被引量:1

Annotation , Cloning and Expression of Dihydroorotate Dehydrogenase fromEimeria tenella
下载PDF
导出
摘要 二氢乳清酸脱氢酶(DHODH)是催化嘧啶从头合成途径中的关键酶,由于顶复门原虫等低等生物与其宿主的DHODH在分子结构上的差异,可以作为研发新型抗顶复门原虫药物的靶标而成为研究的热点。本研究利用电子克隆策略,以疟原虫DHODH氨基酸基因序列为信息探针,搜索球虫基因库(www.sanger.ac.uk/projects/E-tenella/),拼接注释了柔嫩艾美耳球虫(Eimeria tenella)DHODH的基因序列,以E.tenella广东株第2代裂殖子总RNA为模板,利用RT-PCR技术扩增获得EtDHODH ORF基因序列。构建重组表达载体pColdⅠ-EtDHODH,进行原核表达。测序结果显示,EtDHODH的基因大小为1 254bp,SDS-PAGE鉴定结果表明,目的蛋白约45ku。本研究重组表达并纯化了EtDHODH基因,为建立以EtDHODH为靶点的抗球虫药物筛选奠定了基础。 Dihydroorotate dehydrogenase(DHODH)is a key enzyme in de novo pyrimidine biosynthesis,which is explored as a potential drug target of anti-apicomplexa dependent on the molecular structure is different between apicomplexan parasites and their hosts.In this study,according to the technology of in silico cloning,the gene sequence of E.tenella DHODH was predicted fromE.tenellagene datebase using Plasmodium falciparum DHODH gene sequence as a querying probe,which was amplified by RT-PCR from total RNA extracted from total RNA extracted from the second generation merozoite of E.tenella(Guangdong strain).The recombinant plasmid pColdⅠ-EtDHODH was constructed,transformed into E.coli Rosseta(DE3),and induced with IPTG.The results indicated that the E.tenella DHODH ORF was 1 254bp in full length,and the molecular weight was about 45ku.In brief,the E.tenella DHODH recombinant protein was expressed and purified successfully,which provided the foundation for further development of the novel anti-coccidian drugs against E.tenella.
出处 《动物医学进展》 CSCD 北大核心 2013年第7期35-38,共4页 Progress In Veterinary Medicine
基金 国家自然科学基金项目(31201902) 珠江科技新星项目(2012J2200059) 广东省农业科学院院长基金项目(201115) 广东省农业攻关项目(2012A020100001)
关键词 柔嫩艾美耳球虫 二氢乳清酸脱氢酶 电子克隆 原核表达 Eimeria tenella dihydroorotate dehydrogenase in silico cloning expression
  • 相关文献

参考文献14

  • 1戚南山,孙铭飞,廖申权,吴彩艳,吕敏娜,袁建丰,余劲术,蔡建平,李祥瑞.柔嫩艾美耳球虫棒状体颈部蛋白EtRON2基因的克隆及序列分析[J].动物医学进展,2011,32(12):41-46. 被引量:7
  • 2Sun M F, Zhu G, Qin Z H, et al. Functional characterizations of malonyl-CoA: acyl carrier protein trans-acylase (MCAT) in Eimeria tenella [J]. Mol Biochem Parasitol, 2012,4 ( 2 ) : 184 : 20-28.
  • 3黄诒森,张光毅.生物化学与分子生物学[M].3版.北京:科学出版社,2012:87-94.
  • 4Margaret A,Phillips K R. Plasmodium dihydroorotate dehydro- genase a promising target for novel antimalarial chemotherapy [J]. Infect Disord Drug Targets, 2010,3 (10) : 226-239.
  • 5Hortua Triana M A, Huynh M H,Garavito M F, et al. Biochemical and molecular characterization of the pyrimidine bio- synthetic enzyme dihydroorotate dehydrogenase from Toxo- plasma gondii[J]. Mol Biochem Parasitol, 2012, 184 (2) : 71-81.
  • 6Shah P,Kumar S,Tiwari S,et al. 3D-QSAR studies of triazolopyrimidine derivatives of Plasmodiurn falciparum dihydroo rotate dehydrogenase inhibitors using a combination of molecular dynamics, docking, and genetic algorithm-based methods [J]. J Chem Biol,2012,5(3) :91-103.
  • 7O'Doherty C, Schnabl M, Spargo L, et al. Association of DHODH haplotype variants and response to leflunomide treat-ment in rheumatoid arthritis [J]. Pharmaco genomics, 2012,13 (12) : 1427-1434.
  • 8萨姆布鲁克J 拉塞尔DW著 黄培堂 译.分子克隆实验指南[M].北京:科学出版社,2002.481-482.
  • 9Singh N,Cheve G,Avery M A,et al. Comparative protein mod eling of 1-deoxy-D-xylulose-5-phosphate reduetoisomerase en zyme from Plasmodium falciparum: a potential target for an timalarial drug discovery [J]. J Chem Inf Model, 2006,46 (3) 1360-1370.
  • 10Feliciano P R,Cordeiro A T,Costa-Filho A J,et al. Cloning, expression, purification, and characterization of Leishmania major dihydroorotate dehydrogenase [J]. Protein Expression and Purification,2006,48(1) : 98-103.

二级参考文献49

  • 1BETTON J M.High throughput cloning and expression strategies for protein production[J].Biochimie,2004,86:601-605.
  • 2BRAUN P,LABAER J.High throughput protein production for functional proteomics[J].Trends Biotechnol,2003,21:383-388.
  • 3SUN X L,FREASON N,KIRK C,et al.An E.coli expression system optimized for DELLA proteins[J].Protein Expr Purif,2008,58:168-174.
  • 4SORENSEN H P,SPERLING-PETERSEN H U,MORTENSEN K K.A favorable solubility partner for the recombinant expression of streptavidin[J].Protein Expr Purif,2003,32:252-259.
  • 5HANNIG G,MAKRIDES S C.Strategies for optimizing heterologous protein expression in Escherichia coli[J].Trends Biotechnol,1998,16:54-60.
  • 6BANEYX F.Recombinant protein expression in Escherichia coli[J].Curr Opin Biotechnol,1999,10:411-421.
  • 7SORENSEN H P,MORTENSEN K K.Advanced genetic strategies for recombinant protein expression in Escherichia coli[J].J Biotechnol,2005,115:113-128.
  • 8DAVIS G D,ELISEE C,NEWHAM D M,et al.New fusion protein systems designed to give soluble expression in Escherichia coli[J].Biotechnol Bioeng,1999,65:382-388.
  • 9CALOS M P.DNA sequence for a low-level promoter of the lac repressor gene and an 'up' promoter mutation[J].Nature,1978,274:762-765.
  • 10GUZMAN L M,BELIN D,CARSON M J,et al.Tight regulation,modulation and high-level expression by vectors containing the arabinose PBAD promoter[J].J Bacteriol,1995,177:4121-4130.

共引文献183

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部